What does the National Plan to End Parkinson’s Act mean for research, clinical care, and patient outcomes?
We’re joined by Dr. Alice Chen-Plotkin, a leading physician-scientist and non-federal public member on the newly formed federal Advisory Council on Parkinson's Research, Care, and Services.
Dr. Chen-Plotkin breaks down the Council's vital mission to advise the Secretary of Health and Human Services, the cutting-edge science behind Parkinson's biomarkers, and how national strategy can translate into real-world impact for individuals and families living with Parkinson’s today.
Listen, like, and subscribe for more conversations driving Parkinson's advocacy forward!
